Accessibility Tools
Breaking News: Myonex appoints Greg Lavin as Chief Executive Officer as James Lovett retires, joins Board of Directors
With an industry that is constantly changing and evolving, the Myonex team can be your trusted source to identify the right solutions for your projects from clinical to commercial stages. Stay up to date with our latest company news announcements.
Myonex updates
MYONEX APPOINTS GREG LAVIN AS CHIEF EXECUTIVE OFFICER
Ultra-cold capabilities in the spotlight: Val d’Europe visits our Bailly-Romainvilliers site
Myonex Selected by The Leukemia & Lymphoma Society as Preferred Partner for Clinical Trial Pharmacy Card Through CTRx®
Horsham, PA Site Achieves NABP Drug Distributor Accreditation
Myonex Unveils Enhanced Services for a Simplified Experience
Announcement
Myonex’s Journey on Molecule to Market
Drug sourcing
Adalvo and Myonex strengthen existing exclusive clinical trial supply partnership by adding multiple new assets for global markets
EY Announces James Lovett and Mike Cohen of Myonex as an Entrepreneur Of The Year® 2024 Greater Philadelphia Award Winner
Myonex Closes Creapharm Acquisition Expanding Global Services
Myonex Announces Acquisition Of Saveway Compounding Pharmacy To Expand Its Clinical Trial Services Across The Us
Myonex To Acquire Creapharm’s Clinical & Commercial Packaging And Bioservices Business
Authorized As A Pharmaceutical Company By French Regulatory Authorities (Ansm), Creapharm Bioservices Expands Its Scope To Include Advanced Therapy Medicinal Products